Total revenue was €47.7 mm in Q3 2025, while net gaming revenue1 was €51.6 mm in the period, flat versus Q3 2024 (3% in constant currency terms). Mexico revenue was €24.0 mm in Q3 2025, while net gaming revenue was €26.8 mm in the period, flat versus Q3 2024 (5% in constant currency terms). Net loss was €1.7 mm in 9M 2025 versus a net loss of €3.0 mm in 9M 2024. Total cash position of €48.3 mm as of September 30, 2025. Reiterating 2025 net gaming revenue outlook of €220-230 million and Adj. EBITDA2 outlook of €10-15 million. Repurchased $1.7 million of the Company’s shares through November 14, 2025, under the Company’s (recently upsized to) $7.5 million share buyback plan.Madrid, Spain and Tel Aviv, Israel, November 17, 2025 – (GLOBE NEWSWIRE) Codere Online (Nasdaq: CDRO / CDROW, the “Company”), a leading online gaming operator in Spain...

MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced its financial results for the third quarter ended September 30, 2025 and operational highlights. Third Quarter Financial HighlightsBookings:  $1.1M in third quarter 2025 bookings, an 815% increase compared to third quarter of 2024. Private Placements: Successfully completed an additional $0.5M private placement of common stock from an insider, providing further investment towards strategic objectives. Further Improved Balance Sheet: Continuing with its efforts first reported at the end of the second quarter, OneMedNet further improved its balance sheet by reducing total liabilities by an additional $1.9 million during the third quarter, with...

Generated $131 million from the successful business combination with GSR III Acquisition Corp. and related equity financing on October 9, 2025 Sufficient capital to license, construct, build and operate the first-of-a-kind (“FOAK”) SOLOTM micro-modular reactor by 2027 and strengthen supply chain and accelerate scale-up Third party component and fuel supply chain partners secured in the U.S., Europe, and South America for the production of FOAK SOLO by 2027 First deployment site selected in Illinois, including an MOU for up to 50 commercial SOLO units to be deployed Total commercial commitments of 100 SOLO units under non-binding MOUs, reinforcing growing market demand and early-stage adoption across key global sectorsNEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum” or the...

Strengthens Cash Position Five-Fold Amid Strategic Digital Expansion KUALA LUMPUR, Malaysia, Nov. 17, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced its financial results for the first quarter ended September 30, 2025, highlighting a significant increase in liquidity and continued strategic investments in high-potential digital growth initiatives. Key Financial HighlightsSignificant Increase in Cash Position – As of September 30, 2025, Treasure Global held USD 1.25 million in cash and cash equivalents, up from USD 236,895 as of June 30, 2025, representing a more than five-fold increase quarter-over-quarter. This strengthened liquidity provides the Company with enhanced financial flexibility to accelerate execution,...

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (“STSS” or the “Company”), a U.S.-based medical device sales and distribution platform that has adopted a Solana-based treasury strategy, today announced financial results for the third quarter ended September 30, 2025, and provided updates on the execution of its capital markets and digital asset initiatives. “The third quarter was transformative for Sharps Technology,” said Paul K. Danner, Executive Chairman. “Our adoption of a Solana-based treasury strategy, combined with a successful $411 million PIPE financing, has created the strongest balance sheet in the Company’s history. With more than two million SOL in our treasury, growing staking rewards, and a more efficient operating model, Sharps is now better positioned to pursue more viable business strategies...

Sales for the quarter increased 7.5 percent. Organic sales increased 2.8 percent, acquisitions increased sales 3.2 percent, and foreign currency increased sales 1.5 percent. Diluted EPS increased 16.5 percent to $1.13 in the first quarter of fiscal 2026 compared to $0.97 in the same quarter of the prior year. Adjusted Diluted EPS* increased 8.0 percent to $1.21 in the first quarter of fiscal 2026 compared to $1.12 in the same quarter of the prior year. Cash flow from operating activities increased 42.5 percent to $33.4 million in the first quarter of fiscal 2026 compared to $23.4 million in the same quarter of the prior year. The low end of Adjusted Diluted EPS* guidance was raised for the full year ending July 31, 2026 from the previous range of $4.85 to $5.15 per share to the new range of $4.90 to $5.15 per share. GAAP earnings per...

Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; interim and final analyses will occur in 2026Anzu-cel (IMA203) PRAME Cell Therapy: One-time infusion continues to show strong clinical benefit and favorable tolerability in 16 patients with metastatic uveal melanoma in latest update on Phase 1b data presented at the ESMO 2025 Presidential Symposium: cORR of 67%, mDOR of 11.0 months, mPFS of 8.5 months and mOS not reached at 14.3 months mFUIMA203CD8 PRAME Cell Therapy (GEN2): Phase 1a clinical trial ongoing with next data update, including dose escalation data in ovarian cancer, melanoma and synovial sarcoma, planned to be presented at ESMO Immuno-Oncology Congress 2025TCR Bispecifics: IMA402 and IMA401 TCR Bispecifics...

Reports Q3 2025 GAAP Net Loss of $5.5 Million and Nine-Month Net Loss of $28.4 Million Calculates Q3 2025 Adjusted Net Loss of $2.9 Million (Non-GAAP) and Nine-Month Adjusted Net Loss of $10.2 Million (Non-GAAP) Recognized $2.5 Million in Other Income for Q3 and $4.6 Million for Nine Months primarily from California Energy Commission Grant Ended Quarter with $12.0 Million in Cash and Cash EquivalentsCARLSBAD, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — Aptera Motors Corp. (NASDAQ: SEV) (“Aptera” or the “Company”), a solar mobility company pioneering ultra-efficient transportation, today reported its financial results for the third quarter ended September 30, 2025. “Our third quarter was focused on disciplined execution as we prepared for our transition to a public company,” said Chris Anthony, Co-CEO of...

Net Revenues Increased by 50.2% Year-over-Year to RMB15.3 Billion Average Monthly Transacting Customers Reached a Record High of 112.3 Million 3,008 Net New Store Openings; Ended Quarter with 29,214 Stores BEIJING, Nov. 17, 2025 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced its unaudited financial results for the three months ended September 30, 2025. THIRD QUARTER 2025 HIGHLIGHTS1Total net revenues were RMB15,287.1 million (US$2,143.2 million), representing a 50.2% year-over-year increase.Net new store openings were 3,008, comprising 2,979 stores in China (including Hong Kong), 5 stores in Singapore, 21 stores in Malaysia and 3 stores in the U.S. Total number of stores increased to 29,214 at the third quarter end, comprising 18,882 self-operated stores and 10,332 partnership...

RIVERSIDE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — SolarMax Technology, Inc. (Nasdaq SMXT) (“SolarMax” or the “Company”), an integrated solar energy company, reported financial results for the quarter ended September 30, 2025. Third Quarter 2025 Financial HighlightsRevenue: $30.6 million, up 383% from $6.3 million in the third quarter of 2024. Gross profit: $956,000, down 24% from $1.3 million in the third quarter of 2024 due to timing of recognizing revenue versus gross profit on a large industrial project.   Total operating expense: $3.1 million, an $8.2 million reduction from $11.3 million in the third quarter of 2024. Net loss: $2.3 million, or $0.04 per share, a $7.3 million improvement from a net loss of $9.6 million, or $0.21 per share in the third quarter of 2024.David Hsu, CEO of SolarMax, stated, “Our third-quarter...